Terug
Dagbereik
€ 13,11
€ 14,13
52-Weeksbereik
€ 2,86
€ 36,26
Volume
1.390.322
50D / 200D Gem.
€ 23,15
/
€ 14,30
Vorige Slotkoers
€ 13,97
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -7,5 | 0,3 |
| P/B | 2,5 | 2,9 |
| ROE % | -36,6 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 42,50
+205.1%
Low: € 38,00
High: € 48,00
Forward WPA
-€ 2,24
Omzet Sch.
2,3 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,58
€ 0,21 – € 1,03
|
550 M | 2 |
| FY2029 |
-€ 0,94
-€ 1,68 – -€ 0,34
|
300 M | 2 |
| FY2028 |
-€ 1,93
-€ 3,38 – -€ 0,56
|
130 M | 4 |
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -146,72M
PEG of 0,89 suggests growth is underpriced
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-36,61%
ROIC-27,94%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,00
Current Ratio9,95
Interest Coverage0,00
Waardering
P/E Ratio
-7,47
P/B Ratio2,54
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -162,45M |
| ROE | -36,61% | ROA | -30,45% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -146,72M |
| ROIC | -27,94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 9,95 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -7,47 | P/B Ratio | 2,54 |
| P/S Ratio | N/A | PEG Ratio | 0,89 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,21B | Enterprise Value | 1,17B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -162,45M | -129,47M | -96,66M | -104,79M | -71,10M |
| EPS (Diluted) | -1,87 | -2,20 | -2,14 | -2,62 | -1,79 |
| Gross Profit | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -178,70M | -142,26M | -104,96M | -106,99M | -71,49M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 533,43M | 450,98M | 276,95M | 215,65M | 295,95M |
| Total Liabilities | 54,87M | 42,02M | 23,05M | 18,10M | 11,38M |
| Shareholders' Equity | 478,56M | 408,96M | 253,90M | 197,55M | 284,57M |
| Total Debt | 1,19M | 1,43M | 2,42M | 2,57M | 3,29M |
| Cash & Equivalents | 48,30M | 139,48M | 68,54M | 23,70M | 13,81M |
| Current Assets | 515,45M | 438,47M | 266,51M | 208,90M | 290,69M |
| Current Liabilities | 51,80M | 41,76M | 21,62M | 16,55M | 9,02M |